SCHEMBL2947711

SCHEMBL2947711

CCCCCC[C@@H]1C/C=C\CCCCCCCC(=O)O1

nearest known ligand 0.56

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.56
PPARG P37231 2/20 0.44
GRM2 Q14416 11/20 0.38
ALDH1A1 P00352 1/20 0.37
SIRT2 Q8IXJ6 1/20 0.35
PRKCA P17252 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4760067 1.00 CYP1A2 (0.56) CYP1A2PPARGGRM2ALDH1A1SIRT2
SCHEMBL18263241 1.00 CYP1A2 (0.56) CYP1A2PPARGGRM2ALDH1A1SIRT2
SCHEMBL18263240 1.00 CYP1A2 (0.56) CYP1A2PPARGGRM2ALDH1A1SIRT2
SCHEMBL13652118 1.00 CYP1A2 (0.56) CYP1A2PPARGGRM2ALDH1A1SIRT2
SCHEMBL13652119 0.90 CYP1A2 (0.46) CYP1A2PPARGGRM2SIRT2PRKCA
SCHEMBL24729501 0.85 CYP1A2 (0.37) CYP1A2
SCHEMBL29942062 0.85 CYP1A2 (0.37) CYP1A2
SCHEMBL24729436 0.85 CYP1A2 (0.37) CYP1A2
SCHEMBL24668270 0.83 CYP1A2 (0.38) CYP1A2
SCHEMBL25323563 0.80 CYP1A2 (0.57) CYP1A2PPARGGRM2ALDH1A1SIRT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009127011-A1 MODIFIED CONDENSATION POLYMERS COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2009-10-22 WO claimed
WO-2024023457-A1 ADHESIVE COMPOSITION BOSTIK SA (FR) 2024-02-01 WO disclosed
WO-2024023456-A1 RECYCLED ARTICLE AND USES THEREOF BOSTIK SA (FR) 2024-02-01 WO disclosed
WO-2024023455-A1 METHOD FOR RECYCLING A MULTILAYER SYSTEM BOSTIK SA (FR) 2024-02-01 WO disclosed
CN-112574025-B Synthesis method of stannous ricinoleate 中国科学院大连化学物理研究所 2022-07-08 CN disclosed
CN-112574025-A Synthesis method of stannous ricinoleate 中国科学院大连化学物理研究所 2021-03-30 CN disclosed
US-8729176-B2 Polyricinoleate composition and process for producing the same KEIO UNIVERSITY (JP) 2014-05-20 US disclosed
US-8703119-B2 Injectable biodegradable polymer compositions for soft tissue repair and augmentation POLYGENE LTD. (IL) 2014-04-22 US disclosed
EP-2213694-B9 12-HYDROXYSTEARIC ACID COPOLYMER AND METHOD FOR PRODUCING THE SAME UNIV KEIO (JP) 2013-10-09 EP disclosed
EP-2213694-B1 12-HYDROXYSTEARIC ACID COPOLYMER AND METHOD FOR PRODUCING THE SAME UNIV KEIO (JP) 2013-07-31 EP disclosed
US-20090270550-A1 Polyricinoleate composition and process for producing the same KEIO UNIVERSITY 2009-10-29 US disclosed
WO-2009127011-A1 MODIFIED CONDENSATION POLYMERS COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2009-10-22 WO disclosed
WO-2009127011-A1 MODIFIED CONDENSATION POLYMERS COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2009-10-22 WO disclosed
WO-2009127011-A1 MODIFIED CONDENSATION POLYMERS COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2009-10-22 WO disclosed
EP-2065422-A1 RICINOLEIC ACID POLYESTER COMPOSITION AND PROCESS FOR PRODUCTION THEREOF Keio University (JP) 2009-06-03 EP disclosed
WO-2009044403-A2 INJECTABLE BIODEGRADABLE POLYMER COMPOSITIONS FOR SOFT TISSUE REPAIR AND AUGMENTATION JUVENIS LTD. (IL) 2009-04-09 WO disclosed
US-20090082542-A1 NOVEL POLYMERS, USES AND METHODS OF MANUFACTURE THEREOF UNIVERSITE DE MONTREAL (CA) 2009-03-26 US disclosed
US-20070036855-A1 Soft polylactides MASSACHUSETTS INSTITUTE OF TECHNOLOGY 2007-02-15 US disclosed
WO-2006078725-A1 SOFT POLYLACTIDES MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2006-07-27 WO disclosed
US-20040161464-A1 Polymeric formulations for drug delivery EFRAT BIOPOLYMERS LTD. 2004-08-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070036855-A1 Soft polylactides ELOVL6, LIPA, CUTA CYP1A2 1629/4885PPARG 660/4885GRM2 3833/4885
US-20040161464-A1 Polymeric formulations for drug delivery SBDS, AR, CD47 CYP1A2 3008/4885PPARG 1181/4885GRM2 4518/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.